antibody-drug conjugates

gold coins and bars
Biotech

Takeda strikes Innovent pact worth up to $11.4B

The deal, which includes $10.2 billion in milestones, puts the biologics at the center of Takeda’s efforts to establish new growth drivers.
Nick Paul Taylor Oct 22, 2025 9:15am
ESMO Berlin 2025

ESMO: The ADC 'rollercoaster' rides on with next-gen meds

Oct 21, 2025 3:00am
Blue race track
Favicon Fierce Pharma

Merck grows more ambitious about 'workhorse' TROP2 ADC

Oct 20, 2025 4:00pm
An arrow incrementally going up stairs before pointing straight up Blue background

ESMO: Daiichi, Merck move ovarian cancer ADC toward pivotal test

Oct 20, 2025 10:45am
GSK ESMO

GSK says 'stay tuned' for more ADC data as Hansoh posts 49% ORR

Oct 19, 2025 10:40am
Cancer mutation precision medicine oncology targeted

ESMO: Tubulis' next-gen ADC lives up to hype with 59% ORR

Oct 19, 2025 4:15am